MISSION
Advocate for menstrual cycle awareness in psychedelic medicine, empower women through community, and bridge the gap in psychedelic research, education, and support for premenstrual conditions.
OUR WHY
Premenstrual Dysphoric Disorder (PMDD) is a global phenomena impacting an estimated 4.2 million women in the United States alone.
Recent data suggests up to 34% of women with the condition attempt suicide. Despite the overlap in symptoms with other mental health conditions, and the overwhelming need for new treatment options, PMDD is severely understudied in psychedelic research.
PMDD research and treatment development is suicide prevention, and we believe the psychedelic community is well positioned to assist us in this urgent matter.
MEET THE TEAM
MEET THE TEAM
IT’S A GROUP PROJECT
We’re moving quickly, but community support helps us move faster.